MedImmune And National Institutes Of Health Begin Clinical Testing Of A Live, Attenuated Intranasal Vaccine Against An H5N1 Avian Influenza Virus
submited by kickingbird at Jun, 16, 2006 16:18 PM from Medical News Today
MedImmune, Inc.(Nasdaq: MEDI) announced today that the National Institutes of Health (NIH)has begun enrolling participants in a Phase 1 study of an intranasal H5N1influenza vaccine candidate based on the company´s live, attenuated vaccinetechnology. [click link for full article]
See Also:
Latest news in those days:
- UK: Bird flu (avian influenza): latest situation in England 20 hours ago
- US: Highly Pathogenic Avian Influenza Detected in Ottawa County Backyard Flock in Michigan 3 days ago
- GISAID: H5N1 Bird Flu continues to circulate in the United States 6 days ago
- UK: Bird flu (avian influenza): latest situation 6 days ago
- Netherlands: Antibodies to bird flu virus found in dairy cow 6 days ago
[Go Top] [Close Window]
